Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-09-11Clinical Trial Update: Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer [Phase 2]
Phase 2 trial evaluating durvalumab in combination with standard chemotherapy before surgery for variant histology bladder cancers; study te…
-
CLINICAL_TRIALS trial_result · 2023-08-24Clinical Trial Update: Cadonilimab Plus Nab-Paclitaxel for Recurrent or Metastatic Muscle Invasive Bladder Cancer [Phase 2]
Phase 2 trial update of cadonilimab plus nab-paclitaxel for recurrent or metastatic muscle-invasive bladder cancer (bladder cancer).
-
CLINICAL_TRIALS trial_result · 2023-08-22Clinical Trial Update: Checkpoint Inhibitor and Radiation Therapy in Bulky, Node-Positive Bladder Cancer [NA]
Clinical trial update for a checkpoint inhibitor with radiation in bulky, node-positive bladder cancer; study terminated with results posted…
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Evaluation of NanoDoce® in Participants With Urothelial Carcinoma [Phase 1, Phase 2]
Phase 1/2 trial investigating NanoDoce® in urothelial carcinoma and bladder cancer has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer [Phase 3]
Phase 3 clinical trial evaluating BCG with or without gefitinib in high-risk bladder cancer was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene [Phase 1, Phase 2]
Phase 1/2 clinical trial studying A166 in patients with various HER2-expressing or HER2-amplified cancers has completed.
-
CLINICAL_TRIALS trial_result · 2023-07-24Clinical Trial Update: Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG [Phase 3]
Phase 3 trial update for Vicinium in non-muscle invasive bladder cancer previously treated with BCG has completed with results posted in 202…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium [Phase 3]
Phase 3 trial comparing two-drug vs four-drug chemotherapy regimens in advanced urothelial cancer (bladder cancer and related urothelial can…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid Tumor [Phase 2]
Phase 2 clinical trial evaluating FalateScan (Technetium Tc 99m EC20) for safety and efficacy in patients with suspected recurrent or metast…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Intravesical Electromotive Mitomycin After Bacillus Calmette-Guérin Failure [Phase 2]
Phase 2 trial evaluating intravesical electromotive delivery of mitomycin after BCG failure in bladder cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium [Phase 2]
Phase 2 trial evaluating pemetrexed disodium and gemcitabine in advanced urothelial cancers (bladder cancer and transitional cell cancers of…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Chemotherapy in Treating Patients With Early-Stage Bladder Cancer [Phase 2]
Phase 2 clinical trial update on using chemotherapy to treat patients with early-stage bladder cancer.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function [Phase 2]
A Phase 2 clinical trial evaluating combination chemotherapy for advanced urothelial cancer with decreased kidney function has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract [Phase 2]
Phase 2 clinical trial evaluating piritrexim in advanced urinary tract cancers has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Adding Mitomycin to BCG as Adjuvant Intravesical Therapy for High-risk Non-Muscle-invasive Bladder Cancer [Phase 3]
A Phase 3 trial evaluating the addition of mitomycin to BCG as adjuvant intravesical therapy for high-risk non-muscle-invasive bladder cance…
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer [Phase 2]
Phase 2 trial evaluating docetaxel and gemcitabine in progressive regional or metastatic bladder cancer and related transitional cell cancer…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Combination Chemotherapy in Treating Patients With Bladder Cancer [Phase 3]
A Phase 3 clinical trial update on combination chemotherapy for bladder cancer and urethral cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-13Clinical Trial Update: Durvalumab (MEDI4736) and TREmelimumab in NEOadjuvant Bladder Cancer Patients (DUTRENEO) [Phase 2]
Phase 2 trial DUTRENEO evaluating durvalumab and tremelimumab as neoadjuvant therapy in bladder cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-13Clinical Trial Update: Fluorescence Cystoscopy and Optimized MMC in Recurrent Bladder Cancer (FinnBladder 9) [Phase 3]
Phase 3 trial update investigating fluorescence cystoscopy and optimized mitomycin C for recurrent bladder cancer.
-
CLINICAL_TRIALS trial_result · 2023-04-13Clinical Trial Update: VPM1002BC in Recurrent Non-muscle Invasive Bladder Cancer [Phase 1, Phase 2]
Clinical trial update for VPM1002BC in recurrent non-muscle invasive bladder cancer across Phase 1 and Phase 2, status completed.
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: Single-Dose Intravesical Chemotherapy After Diagnostic URS [Phase 3]
Phase 3 trial investigating single-dose intravesical chemotherapy following diagnostic ureteroscopy for upper urinary tract urothelial carci…
-
CLINICAL_TRIALS trial_result · 2023-04-04Clinical Trial Update: Antimicrobial Prophylaxis in Patients Who Underwent a Transurethral Resection of Bladder (TURB) [Phase 2]
Phase 2 clinical trial evaluating antimicrobial prophylaxis in patients undergoing transurethral resection of the bladder (TURB).
-
CLINICAL_TRIALS trial_result · 2023-03-28Clinical Trial Update: A Single-Arm Study of Bempegaldesleukin (NKTR-214) Plus Nivolumab in Cisplatin Ineligible Patients Who Have Locally Advanced or Metastatic Urothelial Cancer [Phase 2]
Phase 2 single-arm study of bempegaldesleukin (NKTR-214) with nivolumab in cisplatin-ineligible, locally advanced or metastatic urothelial c…
-
CLINICAL_TRIALS trial_result · 2023-03-23Clinical Trial Update: Radiation and Durvalumab Immunotherapy As Neoadjuvant Treatment for MIBC [Phase 2]
Phase 2 clinical trial update evaluating radiation plus durvalumab as neoadjuvant therapy for bladder cancer.
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: En-bloc vs Conventional Resection of Primary Bladder Tumor [Phase 3]
Phase 3 clinical trial comparing en-bloc versus conventional resection of primary bladder tumor has completed enrollment.